Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
CSSODRIT
1 other identifier
observational
18,000
1 country
1
Brief Summary
Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ，improve the screening rate of diabetic retinopathy, and reduce the blindness rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2024
CompletedFirst Submitted
Initial submission to the registry
June 22, 2024
CompletedFirst Posted
Study publicly available on registry
June 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2025
CompletedJuly 10, 2024
July 1, 2024
1 year
June 22, 2024
July 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Classification of diabetic retinopathy
Fundus images were taken by fundus camera and graded
At screening
Secondary Outcomes (7)
blood routine examination
At screening
OCTA imaging indicators
At screening
blood biochemistry
At screening
glycosylated hemoglobin
At screening
glycated albumin
At screening
- +2 more secondary outcomes
Study Arms (1)
Diabetic retinopathy screening group
Diabetes patients in the community to accept unified eye test, confirm whether patients with diabetic retinopathy
Eligibility Criteria
Patients with diabetes receive a unified eye examination in the community to confirm whether they have diabetic retinopathy
You may qualify if:
- \- 1: Clear awareness, barrier-free communication
- : diabetes
You may not qualify if:
- : Have left the registered home address
- : In the last 6 months, you have not lived in your place of residence
- : Have a serious mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Li Xiaoronglead
- Tianjin Medical University Eye Hospitalcollaborator
Study Sites (1)
Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, 300000, China
Biospecimen
Blood and Midstream clean urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaorong Li, professor
Tianjin Medical University Eye Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PROFESSOR
Study Record Dates
First Submitted
June 22, 2024
First Posted
June 27, 2024
Study Start
March 28, 2024
Primary Completion
March 28, 2025
Study Completion
March 28, 2025
Last Updated
July 10, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share